Cargando…
The emerging role of PET imaging in dementia
A compelling need in the field of neurodegenerative diseases is the development and validation of biomarkers for early identification and differential diagnosis. The availability of positron emission tomography (PET) neuroimaging tools for the assessment of molecular biology and neuropathology has o...
Autores principales: | Iaccarino, Leonardo, Sala, Arianna, Caminiti, Silvia Paola, Perani, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639932/ https://www.ncbi.nlm.nih.gov/pubmed/29071066 http://dx.doi.org/10.12688/f1000research.11603.1 |
Ejemplares similares
-
Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging
por: Cerami, Chiara, et al.
Publicado: (2017) -
Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET
por: Iaccarino, Leonardo, et al.
Publicado: (2019) -
Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria
por: Caminiti, Silvia Paola, et al.
Publicado: (2019) -
A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
por: Daniela, Perani, et al.
Publicado: (2014) -
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
por: Caminiti, Silvia Paola, et al.
Publicado: (2018)